Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for epidermolytic hyperkeratosis 2 has been reported in the published literature.
No clinical trials have been registered for epidermolytic hyperkeratosis 2.
7 publications have been identified in PubMed for epidermolytic hyperkeratosis 2. Research spans Case Report / Case Series (57%), Epidemiology / Natural History (29%), and Diagnostic / Biomarker (14%).
Süßmuth K (2026). [PMID: 41892076](https://pubmed.ncbi.nlm.nih.gov/41892076/). *Dermatopathology (Basel)*. [Diagnostic / Biomarker]
Singh S (2026). [PMID: 41494726](https://pubmed.ncbi.nlm.nih.gov/41494726/). *BMJ Case Rep*. [Case Report / Case Series]
Erickson KL (2025). [PMID: 39481032](https://pubmed.ncbi.nlm.nih.gov/39481032/). *Am J Dermatopathol*. [Epidemiology / Natural History]
Smits E (2025). [PMID: 40741111](https://pubmed.ncbi.nlm.nih.gov/40741111/). *Clin Case Rep*. [Case Report / Case Series]
Yilmaz K (2025). [PMID: 40468713](https://pubmed.ncbi.nlm.nih.gov/40468713/). *Acta Derm Venereol*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
van der Velden JJAJ (2024). [PMID: 39072839](https://pubmed.ncbi.nlm.nih.gov/39072839/). *J Dermatol*. [Case Report / Case Series]